Endometrial Regeneration Therapy using Platelet-Rich Plasma (PRP) is a groundbreaking approach aimed at revitalizing the endometrium, the uterine lining and enhancing the prospects of a successful pregnancy.
Platelet-Rich Plasma (PRP) is a biological material derived from the patient’s blood. It contains a high platelet concentration that releases growth factors, stimulating tissue regeneration. PRP therapy is a gentle and natural method designed to optimize the endometrium for successful implantation.
Adenomyosis and internal endometriosis:
PRP therapy is being investigated as a potential adjunctive approach in women with adenomyosis and internal endometriosis, conditions that may be associated with reduced fertility.
Chronic endometritis and endometrial microbiome imbalance:
In cases of chronic endometritis or alterations of the endometrial microbiome, PRP is considered an experimental adjunct in the context of endometrial dysfunction.
Thin or refractory endometrium:
In women with persistently thin or unresponsive endometrium, PRP has been explored in selected studies as a supportive intervention.
Asherman’s syndrome:
In Asherman’s syndrome, primary treatment is surgical. PRP has been evaluated as an adjunctive option in selected protocols.
Reduced subendometrial vascular flow (VFI):
A reduced VFI may be associated with impaired endometrial function. The potential role of PRP in this context is still under investigation.
Recurrent implantation failure and miscarriage:
In cases of recurrent implantation failure or recurrent miscarriage, PRP is considered an experimental, adjunctive approach.
Immunological or rheological implantation issues:
In suspected immunological or rheological factors affecting implantation, the use of PRP remains within the scope of ongoing clinical research.
We understand that each case is unique. Endometrial regeneration with PRP is considered as a potential adjunctive approach in selected cases within reproductive medicine.
Dr. Christos Roukoudis provides guidance throughout the diagnostic and therapeutic process, ensuring that decisions are based on clinical findings and individualized medical assessment.